Recombinant Human Proteins (Cambridge International A-Level Biology)
Spec point —
19.2.1· explain the advantages of using recombinant human proteins to treat disease, using the examples insulin, factor VIII and adenosine deaminase
Recombinant human proteins
-
DNA that has been altered by introducing nucleotides from another source is called recombinant DNA(rDNA)
- DNA from one organism has been recombined with DNA from another source
-
If the organism contains nucleotides from a different species it is called a **transgenic **organism
-
Any organism that has received genetic material from another source is a genetically modified organism (GMO)
-
Recombinant DNA has been used to produce** recombinant proteins** (RP), recombinant human proteins can be identical to the natural human protein, or deliberately modified (e.g. faster-acting insulin)
-
Recombinant proteins are generated using microorganisms such as bacteria, yeast, or animal cells in culture
- They are used for research purposes and for treatments (e.g., diabetes, cancer, infectious diseases, haemophilia)
-
Most recombinant human proteins are produced using eukaryotic cells (e.g. yeast, or animal cells in culture) rather than using prokaryotic cells because eukaryotic cells will carry out the post-translational modification
-
Due to the presence of Golgi apparatus (and/or enzymes) that is required to produce a suitable human protein
-
The advantages of genetic engineering organisms to produce recombinant human proteins are:
- More cost-effective to produce large volumes (i.e. there is unlimited availability)
- Simpler (with regards to using prokaryotic cells)
- Faster to produce many proteins
- Reliable supply available
- The proteins are engineered to be identical to human proteins or have modifications that are beneficial
- It can solve the issue for people who have moral, ethical or religious concerns against using cow or pork-produced proteins
Insulin
-
In 1982, insulin was the first recombinant human protein to be approved for use in diabetes treatment
-
Bacteria plasmids are modified to include the human insulin gene
- Restriction endonucleases are used to cut open plasmids and DNA ligase is used to splice the plasmid and human DNA together
-
These recombinant plasmids are then inserted into the bacterium Escherichia coli by transformation (bath of calcium ions and then heat or electric shock)
-
Once the transgenic bacteria are identified (by the markers), they are isolated, purified and placed into fermenters that provide optimal conditions
-
The transgenic bacteria multiply by binary fission and express the human protein - insulin, which is eventually extracted and purified
-
The advantages for scientists to use recombinant insulin are:
- It is identical to human insulin, unless modified to have different properties (eg. act faster, which is useful for taking immediately after a meal or to act more slowly)
- There is a reliable supply available to meet demand (no need to depend on the availability of meat stock)
- Fewer ethical, moral or religious concerns (proteins are not extracted from cows or pigs)
- Fewer rejection problems, side effects or allergic reactions
- Cheaper to produce in large volumes
- Is useful for people who have animal insulin tolerance
Factor VIII
-
Factor VIII is a blood-clotting protein that haemophiliacs cannot produce
-
Kidney and ovary hamster cells have been genetically modified to produce Factor VIII
-
Once modified, these recombinant cells are placed into a fermenter and cultured
-
Due to the optimal conditions in the fermenter, the hamster cells constantly express Factor VIII which can then be extracted, purified and used as an injectable treatment for haemophilia
-
The advantages for scientists to use recombinant Factor VIII are:
- Fewer ethical, moral or religious concerns (proteins are not extracted from human blood)
- Less risk of transmitting infection (eg. HIV) or disease
- Greater production rate
Adenosine deaminase
-
Adenosine deaminase (ADA) is an enzyme used to treat the inherited condition called Adenosine Deaminase Deficiency
-
ADA Deficiency is a common cause of Severe Combined Immunodeficiency (SCID)
-
This is because the immune system is damaged
-
The larva of the cabbage looper moth (Trichoplusia ni) has been genetically modified (using a virus vector) to produce the enzyme adenosine deaminase so that it can be used as a treatment whilst the patients wait for gene therapy or when gene therapy is not possible
-
The advantages for scientists to use recombinant adenosine deaminase are:
- Fewer ethical, moral or religious concerns (proteins are not extracted from cows)
- Less risk of transmitting infection or disease (from cows)
- More reliable production of the enzyme
- Faster to produce many proteins
Exam Hint Learn how recombinant human insulin is produced and the advantages of recombinant human insulin being used to treat diabetes.
Was this revision note helpful?
Build on this topic